questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the modelling assumptions underpinning projected PSMA PET-CT activity volumes within the forthcoming PET-CT commissioning arrangements are (a) forward-looking and (b) reflect clinical demand.
answerText: NHS England is responsible for commissioning prostate‑specific membrane antigen (PSMA) radiotracers for positron emission tomography–computed tomography (PET‑CT) imaging for adults with high‑risk primary or recurrent prostate cancer. The commissioning pol...
heading: Prostate Cancer: Screening